APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Insulin Degludec and Insulin Aspart Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Insulin Degludec and Insulin Aspart Injection Industry Growth and Trends Forecast to 2032

27 December 202574 pages

Choose your research edition.

Industry ResearchInsulin Degludec and Insulin Aspart Injection Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Insulin Degludec and Insulin Aspart Injection Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Insulin Degludec and Insulin Aspart Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insulin Degludec and Insulin Aspart Injection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Insulin Degludec and Insulin Aspart Injection Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Insulin Degludec and Insulin Aspart Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Insulin Degludec and Insulin Aspart Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Insulin Degludec and Insulin Aspart Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Insulin Degludec and Insulin Aspart Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Insulin Degludec and Insulin Aspart Injection include Sihuan Pharmaceutical Holdings Group and Novo Nordisk A/S among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Insulin Degludec and Insulin Aspart Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Insulin Degludec and Insulin Aspart Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Insulin Degludec and Insulin Aspart Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Insulin Degludec and Insulin Aspart Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Insulin Degludec and Insulin Aspart Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Insulin Degludec and Insulin Aspart Injection Market by Company

Sihuan Pharmaceutical Holdings Group

Novo Nordisk A/S

Insulin Degludec and Insulin Aspart Injection Segment by Type

Long-acting Insulin

Rapid-acting Insulin

Insulin Degludec and Insulin Aspart Injection Segment by Application

Clinic

Hospital

Others

Insulin Degludec and Insulin Aspart Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Degludec and Insulin Aspart Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin Degludec and Insulin Aspart Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Degludec and Insulin Aspart Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Insulin Degludec and Insulin Aspart Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Insulin Degludec and Insulin Aspart Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Long-acting Insulin Table 2. Major Company of Rapid-acting Insulin Table 3. Global Insulin Degludec and Insulin Aspart Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Insulin Degludec and Insulin Aspart Injection Sales by Type (2021-2026) & (K Units) Table 5. Global Insulin Degludec and Insulin Aspart Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Insulin Degludec and Insulin Aspart Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Insulin Degludec and Insulin Aspart Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Insulin Degludec and Insulin Aspart Injection Price by Type (2021-2026) & (US$/Unit) Table 9. Global Insulin Degludec and Insulin Aspart Injection Sales by Type (2027-2032) & (K Units) Table 10. Global Insulin Degludec and Insulin Aspart Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Insulin Degludec and Insulin Aspart Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Insulin Degludec and Insulin Aspart Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Insulin Degludec and Insulin Aspart Injection Price by Type (2027-2032) & (US$/Unit) Table 14. North America Insulin Degludec and Insulin Aspart Injection Sales by Type (2021-2026) & (K Units) Table 15. North America Insulin Degludec and Insulin Aspart Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Insulin Degludec and Insulin Aspart Injection Sales by Type (2021-2026) & (K Units) Table 17. Europe Insulin Degludec and Insulin Aspart Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Insulin Degludec and Insulin Aspart Injection Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Insulin Degludec and Insulin Aspart Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Insulin Degludec and Insulin Aspart Injection Sales by Type (2021-2026) & (K Units) Table 21. Latin America Insulin Degludec and Insulin Aspart Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Insulin Degludec and Insulin Aspart Injection Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Insulin Degludec and Insulin Aspart Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Insulin Degludec and Insulin Aspart Injection Industry Trends Table 25. Insulin Degludec and Insulin Aspart Injection Industry Drivers Table 26. Insulin Degludec and Insulin Aspart Injection Industry Opportunities and Challenges Table 27. Insulin Degludec and Insulin Aspart Injection Industry Restraints Table 28. Global Insulin Degludec and Insulin Aspart Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Insulin Degludec and Insulin Aspart Injection Revenue Market Share by Company (2021-2026) Table 30. Global Insulin Degludec and Insulin Aspart Injection Sales by Company (2021-2026) & (K Units) Table 31. Global Insulin Degludec and Insulin Aspart Injection Sales Share by Company (2021-2026) Table 32. Global Insulin Degludec and Insulin Aspart Injection Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Insulin Degludec and Insulin Aspart Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Insulin Degludec and Insulin Aspart Injection Major Company Production Sites and Headquarters Table 35. Global Insulin Degludec and Insulin Aspart Injection Company, Product Type & Application Table 36. Global Insulin Degludec and Insulin Aspart Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Insulin Degludec and Insulin Aspart Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Insulin Degludec and Insulin Aspart Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Insulin Degludec and Insulin Aspart Injection Sales by Region (2021-2026) & (K Units) Table 41. Global Insulin Degludec and Insulin Aspart Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Insulin Degludec and Insulin Aspart Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Insulin Degludec and Insulin Aspart Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Insulin Degludec and Insulin Aspart Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Insulin Degludec and Insulin Aspart Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Insulin Degludec and Insulin Aspart Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Insulin Degludec and Insulin Aspart Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Insulin Degludec and Insulin Aspart Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Insulin Degludec and Insulin Aspart Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Insulin Degludec and Insulin Aspart Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Insulin Degludec and Insulin Aspart Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Insulin Degludec and Insulin Aspart Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Insulin Degludec and Insulin Aspart Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Insulin Degludec and Insulin Aspart Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Insulin Degludec and Insulin Aspart Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Insulin Degludec and Insulin Aspart Injection Sales by Application (2027-2032) & (K Units) Table 57. Global Insulin Degludec and Insulin Aspart Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Insulin Degludec and Insulin Aspart Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Insulin Degludec and Insulin Aspart Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Insulin Degludec and Insulin Aspart Injection Price by Application (2027-2032) & (US$/Unit) Table 61. North America Insulin Degludec and Insulin Aspart Injection Sales by Application (2021-2026) & (K Units) Table 62. North America Insulin Degludec and Insulin Aspart Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Insulin Degludec and Insulin Aspart Injection Sales by Application (2021-2026) & (K Units) Table 64. Europe Insulin Degludec and Insulin Aspart Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Insulin Degludec and Insulin Aspart Injection Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Insulin Degludec and Insulin Aspart Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Insulin Degludec and Insulin Aspart Injection Sales by Application (2021-2026) & (K Units) Table 68. Latin America Insulin Degludec and Insulin Aspart Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Insulin Degludec and Insulin Aspart Injection Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Insulin Degludec and Insulin Aspart Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Sihuan Pharmaceutical Holdings Group Company Information Table 72. Sihuan Pharmaceutical Holdings Group Business Overview Table 73. Sihuan Pharmaceutical Holdings Group Insulin Degludec and Insulin Aspart Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Sihuan Pharmaceutical Holdings Group Insulin Degludec and Insulin Aspart Injection Product Portfolio Table 75. Sihuan Pharmaceutical Holdings Group Recent Development Table 76. Novo Nordisk A/S Company Information Table 77. Novo Nordisk A/S Business Overview Table 78. Novo Nordisk A/S Insulin Degludec and Insulin Aspart Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Novo Nordisk A/S Insulin Degludec and Insulin Aspart Injection Product Portfolio Table 80. Novo Nordisk A/S Recent Development Table 81. North America Insulin Degludec and Insulin Aspart Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 82. North America Insulin Degludec and Insulin Aspart Injection Sales by Country (2021-2026) & (K Units) Table 83. North America Insulin Degludec and Insulin Aspart Injection Sales Market Share by Country (2021-2026) Table 84. North America Insulin Degludec and Insulin Aspart Injection Sales Forecast by Country (2027-2032) & (K Units) Table 85. North America Insulin Degludec and Insulin Aspart Injection Sales Market Share Forecast by Country (2027-2032) Table 86. North America Insulin Degludec and Insulin Aspart Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 87. North America Insulin Degludec and Insulin Aspart Injection Market Size by Country (2021-2026) & (US$ Million) Table 88. North America Insulin Degludec and Insulin Aspart Injection Market Share by Country (2021-2026) Table 89. North America Insulin Degludec and Insulin Aspart Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 90. North America Insulin Degludec and Insulin Aspart Injection Market Share Forecast by Country (2027-2032) Table 91. Europe Insulin Degludec and Insulin Aspart Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 92. Europe Insulin Degludec and Insulin Aspart Injection Sales by Country (2021-2026) & (K Units) Table 93. Europe Insulin Degludec and Insulin Aspart Injection Sales Market Share by Country (2021-2026) Table 94. Europe Insulin Degludec and Insulin Aspart Injection Sales Forecast by Country (2027-2032) & (K Units) Table 95. Europe Insulin Degludec and Insulin Aspart Injection Sales Market Share Forecast by Country (2027-2032) Table 96. Europe Insulin Degludec and Insulin Aspart Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. Europe Insulin Degludec and Insulin Aspart Injection Market Size by Country (2021-2026) & (US$ Million) Table 98. Europe Insulin Degludec and Insulin Aspart Injection Market Share by Country (2021-2026) Table 99. Europe Insulin Degludec and Insulin Aspart Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. Europe Insulin Degludec and Insulin Aspart Injection Market Share Forecast by Country (2027-2032) Table 101. Asia-Pacific Insulin Degludec and Insulin Aspart Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. Asia-Pacific Insulin Degludec and Insulin Aspart Injection Sales by Country (2021-2026) & (K Units) Table 103. Asia-Pacific Insulin Degludec and Insulin Aspart Injection Sales Market Share by Country (2021-2026) Table 104. Asia-Pacific Insulin Degludec and Insulin Aspart Injection Sales Forecast by Country (2027-2032) & (K Units) Table 105. Asia-Pacific Insulin Degludec and Insulin Aspart Injection Sales Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Insulin Degludec and Insulin Aspart Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Insulin Degludec and Insulin Aspart Injection Market Size by Country (2021-2026) & (US$ Million) Table 108. Asia-Pacific Insulin Degludec and Insulin Aspart Injection Market Share by Country (2021-2026) Table 109. Asia-Pacific Insulin Degludec and Insulin Aspart Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Asia-Pacific Insulin Degludec and Insulin Aspart Injection Market Share Forecast by Country (2027-2032) Table 111. Latin America Insulin Degludec and Insulin Aspart Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Latin America Insulin Degludec and Insulin Aspart Injection Sales by Country (2021-2026) & (K Units) Table 113. Latin America Insulin Degludec and Insulin Aspart Injection Sales Market Share by Country (2021-2026) Table 114. Latin America Insulin Degludec and Insulin Aspart Injection Sales Forecast by Country (2027-2032) & (K Units) Table 115. Latin America Insulin Degludec and Insulin Aspart Injection Sales Market Share Forecast by Country (2027-2032) Table 116. Latin America Insulin Degludec and Insulin Aspart Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Latin America Insulin Degludec and Insulin Aspart Injection Market Size by Country (2021-2026) & (US$ Million) Table 118. Latin America Insulin Degludec and Insulin Aspart Injection Market Share by Country (2021-2026) Table 119. Latin America Insulin Degludec and Insulin Aspart Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Latin America Insulin Degludec and Insulin Aspart Injection Market Share Forecast by Country (2027-2032) Table 121. Middle East and Africa Insulin Degludec and Insulin Aspart Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Middle East and Africa Insulin Degludec and Insulin Aspart Injection Sales by Country (2021-2026) & (K Units) Table 123. Middle East and Africa Insulin Degludec and Insulin Aspart Injection Sales Market Share by Country (2021-2026) Table 124. Middle East and Africa Insulin Degludec and Insulin Aspart Injection Sales Forecast by Country (2027-2032) & (K Units) Table 125. Middle East and Africa Insulin Degludec and Insulin Aspart Injection Sales Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Insulin Degludec and Insulin Aspart Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Insulin Degludec and Insulin Aspart Injection Market Size by Country (2021-2026) & (US$ Million) Table 128. Middle East and Africa Insulin Degludec and Insulin Aspart Injection Market Share by Country (2021-2026) Table 129. Middle East and Africa Insulin Degludec and Insulin Aspart Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Middle East and Africa Insulin Degludec and Insulin Aspart Injection Market Share Forecast by Country (2027-2032) Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. Insulin Degludec and Insulin Aspart Injection Distributors List Table 134. Insulin Degludec and Insulin Aspart Injection Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Insulin Degludec and Insulin Aspart Injection Image Figure 2. Global Insulin Degludec and Insulin Aspart Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insulin Degludec and Insulin Aspart Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Insulin Degludec and Insulin Aspart Injection Sales (2021-2032) & (K Units) Figure 5. Long-acting Insulin Image Figure 6. Global Long-acting Insulin Sales YoY Growth (2021-2032) & (K Units) Figure 7. Rapid-acting Insulin Image Figure 8. Global Rapid-acting Insulin Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Insulin Degludec and Insulin Aspart Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Insulin Degludec and Insulin Aspart Injection Market Share by Type 2025 VS 2032 Figure 11. North America Insulin Degludec and Insulin Aspart Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Insulin Degludec and Insulin Aspart Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Insulin Degludec and Insulin Aspart Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Insulin Degludec and Insulin Aspart Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Insulin Degludec and Insulin Aspart Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Insulin Degludec and Insulin Aspart Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Insulin Degludec and Insulin Aspart Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Insulin Degludec and Insulin Aspart Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Insulin Degludec and Insulin Aspart Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Insulin Degludec and Insulin Aspart Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Insulin Degludec and Insulin Aspart Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Clinic Image Figure 24. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Insulin Degludec and Insulin Aspart Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Insulin Degludec and Insulin Aspart Injection Market Share by Application 2025 VS 2032 Figure 31. North America Insulin Degludec and Insulin Aspart Injection Sales Market Share in Volume by Application in 2025 Figure 32. North America Insulin Degludec and Insulin Aspart Injection Sales Market Share in Value by Application in 2025 Figure 33. Europe Insulin Degludec and Insulin Aspart Injection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Insulin Degludec and Insulin Aspart Injection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Insulin Degludec and Insulin Aspart Injection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Insulin Degludec and Insulin Aspart Injection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Insulin Degludec and Insulin Aspart Injection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Insulin Degludec and Insulin Aspart Injection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Insulin Degludec and Insulin Aspart Injection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Insulin Degludec and Insulin Aspart Injection Sales Market Share in Value by Application in 2025 Figure 41. North America Insulin Degludec and Insulin Aspart Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Insulin Degludec and Insulin Aspart Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Insulin Degludec and Insulin Aspart Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Insulin Degludec and Insulin Aspart Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Insulin Degludec and Insulin Aspart Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Insulin Degludec and Insulin Aspart Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Insulin Degludec and Insulin Aspart Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Insulin Degludec and Insulin Aspart Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Insulin Degludec and Insulin Aspart Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Insulin Degludec and Insulin Aspart Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Insulin Degludec and Insulin Aspart Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Insulin Degludec and Insulin Aspart Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Insulin Degludec and Insulin Aspart Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Insulin Degludec and Insulin Aspart Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Insulin Degludec and Insulin Aspart Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Insulin Degludec and Insulin Aspart Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Insulin Degludec and Insulin Aspart Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Insulin Degludec and Insulin Aspart Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Insulin Degludec and Insulin Aspart Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Insulin Degludec and Insulin Aspart Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Insulin Degludec and Insulin Aspart Injection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Insulin Degludec and Insulin Aspart Injection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Long-acting Insulin
  • Rapid-acting Insulin
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Sihuan Pharmaceutical Holdings Group
  • Novo Nordisk A/S

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Insulin Degludec and Insulin Aspart Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Insulin Degludec and Insulin Aspart Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Insulin Degludec and Insulin Aspart Injection Market by Type
  6. 1.3.1 Long-acting Insulin
  7. 1.3.2 Rapid-acting Insulin
  8. 1.4 Global Insulin Degludec and Insulin Aspart Injection Market Size by Type
  9. 1.4.1 Global Insulin Degludec and Insulin Aspart Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Insulin Degludec and Insulin Aspart Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Insulin Degludec and Insulin Aspart Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Insulin Degludec and Insulin Aspart Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Insulin Degludec and Insulin Aspart Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Insulin Degludec and Insulin Aspart Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Insulin Degludec and Insulin Aspart Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Insulin Degludec and Insulin Aspart Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Insulin Degludec and Insulin Aspart Injection Industry Trends
  2. 2.2 Insulin Degludec and Insulin Aspart Injection Industry Drivers
  3. 2.3 Insulin Degludec and Insulin Aspart Injection Industry Opportunities and Challenges
  4. 2.4 Insulin Degludec and Insulin Aspart Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Insulin Degludec and Insulin Aspart Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Insulin Degludec and Insulin Aspart Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Insulin Degludec and Insulin Aspart Injection Price (2021-2026)
  4. 3.4 Global Insulin Degludec and Insulin Aspart Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Insulin Degludec and Insulin Aspart Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Insulin Degludec and Insulin Aspart Injection Company, Product Type & Application
  7. 3.7 Global Insulin Degludec and Insulin Aspart Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Insulin Degludec and Insulin Aspart Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Insulin Degludec and Insulin Aspart Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Insulin Degludec and Insulin Aspart Injection Tier 1, Tier 2, and Tier 3
4 Insulin Degludec and Insulin Aspart Injection Regional Status and Outlook
  1. 4.1 Global Insulin Degludec and Insulin Aspart Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Insulin Degludec and Insulin Aspart Injection Historic Market Size by Region
  3. 4.2.1 Global Insulin Degludec and Insulin Aspart Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Insulin Degludec and Insulin Aspart Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Insulin Degludec and Insulin Aspart Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Insulin Degludec and Insulin Aspart Injection Forecasted Market Size by Region
  7. 4.3.1 Global Insulin Degludec and Insulin Aspart Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Insulin Degludec and Insulin Aspart Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Insulin Degludec and Insulin Aspart Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Insulin Degludec and Insulin Aspart Injection by Application
  1. 5.1 Insulin Degludec and Insulin Aspart Injection Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Insulin Degludec and Insulin Aspart Injection Market Size by Application
  6. 5.2.1 Global Insulin Degludec and Insulin Aspart Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Insulin Degludec and Insulin Aspart Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Insulin Degludec and Insulin Aspart Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Insulin Degludec and Insulin Aspart Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Insulin Degludec and Insulin Aspart Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Insulin Degludec and Insulin Aspart Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Insulin Degludec and Insulin Aspart Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Insulin Degludec and Insulin Aspart Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sihuan Pharmaceutical Holdings Group
  2. 6.1.1 Sihuan Pharmaceutical Holdings Group Company Information
  3. 6.1.2 Sihuan Pharmaceutical Holdings Group Business Overview
  4. 6.1.3 Sihuan Pharmaceutical Holdings Group Insulin Degludec and Insulin Aspart Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sihuan Pharmaceutical Holdings Group Insulin Degludec and Insulin Aspart Injection Product Portfolio
  6. 6.1.5 Sihuan Pharmaceutical Holdings Group Recent Developments
  7. 6.2 Novo Nordisk A/S
  8. 6.2.1 Novo Nordisk A/S Company Information
  9. 6.2.2 Novo Nordisk A/S Business Overview
  10. 6.2.3 Novo Nordisk A/S Insulin Degludec and Insulin Aspart Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novo Nordisk A/S Insulin Degludec and Insulin Aspart Injection Product Portfolio
  12. 6.2.5 Novo Nordisk A/S Recent Developments
7 North America by Country
  1. 7.1 North America Insulin Degludec and Insulin Aspart Injection Sales by Country
  2. 7.1.1 North America Insulin Degludec and Insulin Aspart Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Insulin Degludec and Insulin Aspart Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Insulin Degludec and Insulin Aspart Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Insulin Degludec and Insulin Aspart Injection Market Size by Country
  6. 7.2.1 North America Insulin Degludec and Insulin Aspart Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Insulin Degludec and Insulin Aspart Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Insulin Degludec and Insulin Aspart Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Insulin Degludec and Insulin Aspart Injection Sales by Country
  2. 8.1.1 Europe Insulin Degludec and Insulin Aspart Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Insulin Degludec and Insulin Aspart Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Insulin Degludec and Insulin Aspart Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Insulin Degludec and Insulin Aspart Injection Market Size by Country
  6. 8.2.1 Europe Insulin Degludec and Insulin Aspart Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Insulin Degludec and Insulin Aspart Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Insulin Degludec and Insulin Aspart Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Insulin Degludec and Insulin Aspart Injection Sales by Country
  2. 9.1.1 Asia-Pacific Insulin Degludec and Insulin Aspart Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Insulin Degludec and Insulin Aspart Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Insulin Degludec and Insulin Aspart Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Insulin Degludec and Insulin Aspart Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Insulin Degludec and Insulin Aspart Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Insulin Degludec and Insulin Aspart Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Insulin Degludec and Insulin Aspart Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Insulin Degludec and Insulin Aspart Injection Sales by Country
  2. 10.1.1 South America Insulin Degludec and Insulin Aspart Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Insulin Degludec and Insulin Aspart Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Insulin Degludec and Insulin Aspart Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Insulin Degludec and Insulin Aspart Injection Market Size by Country
  6. 10.2.1 South America Insulin Degludec and Insulin Aspart Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Insulin Degludec and Insulin Aspart Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Insulin Degludec and Insulin Aspart Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Insulin Degludec and Insulin Aspart Injection Sales by Country
  2. 11.1.1 Middle East and Africa Insulin Degludec and Insulin Aspart Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Insulin Degludec and Insulin Aspart Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Insulin Degludec and Insulin Aspart Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Insulin Degludec and Insulin Aspart Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Insulin Degludec and Insulin Aspart Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Insulin Degludec and Insulin Aspart Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Insulin Degludec and Insulin Aspart Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Insulin Degludec and Insulin Aspart Injection Value Chain Analysis
  2. 12.1.1 Insulin Degludec and Insulin Aspart Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Insulin Degludec and Insulin Aspart Injection Production Mode & Process
  7. 12.2 Insulin Degludec and Insulin Aspart Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Insulin Degludec and Insulin Aspart Injection Distributors
  10. 12.2.3 Insulin Degludec and Insulin Aspart Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst